Frontlight ResearchEarly access
Huntington's disease trials in Israel
2 of 3 trials · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
- Where
- Tel Aviv
- Age
- 21 years to 70 years
- People
- 770 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07326709 · EU 2025-522227-99-00 - Phase 1/2Taking peopleA Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HD
- Where
- Kfar Saba, Tel Aviv
- Age
- 25 years to 60 years
- People
- 68 worldwide
- Run by
- Vico Therapeutics B. V.
See details and how to joinNCT05822908 · EU 2024-514328-18-00